Abstract
Due to their beneficial hemodynamic and metabolic effects, beta-blockers are indispensable in the intensive care of a wide range of disease states, especially in the treatment of cardiac arrhythmias and acute coronary syndromes. Intravenous administration allows for rapid onset of action and prompt adjustment of dosage according to therapeutic response.
Available molecules differ not only in pharmacological properties but also in the degree of clinical experience in individual indications. Therefore, it is important to follow professional recommendations and approved indications when administering them.